Cargando…
Changes in renal vessels associated with long-term administration of angiotensin converting enzyme inhibitor in Zucker fatty rats
Background Recently, we showed that long-term angiotensin receptor blocker (ARB) administration induced unusual proliferative changes in smooth muscle cells (SMCs) of afferent arterioles of the kidneys of Zucker fatty rats (ZFRs). In this study, we investigated renal afferent arteriolar changes indu...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Society of Smooth Muscle Research
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364377/ https://www.ncbi.nlm.nih.gov/pubmed/28260705 http://dx.doi.org/10.1540/jsmr.53.20 |
_version_ | 1782517305008193536 |
---|---|
author | Nakanishi, Kazushige Nagai, Yohko Akimoto, Tatsuo Yamanaka, Nobuaki |
author_facet | Nakanishi, Kazushige Nagai, Yohko Akimoto, Tatsuo Yamanaka, Nobuaki |
author_sort | Nakanishi, Kazushige |
collection | PubMed |
description | Background Recently, we showed that long-term angiotensin receptor blocker (ARB) administration induced unusual proliferative changes in smooth muscle cells (SMCs) of afferent arterioles of the kidneys of Zucker fatty rats (ZFRs). In this study, we investigated renal afferent arteriolar changes induced by the long-term administration of an angiotensin converting enzyme inhibitor (ACEI) in ZFRs. Materials and Methods Fourteen 6-week-old male ZFRs were divided into two groups (n=14): the ZFR+ACEI group (n=6) was fed a standard diet containing ACEI (Enalapril, 2 mg/kg/day), and the ZFR control group (n=8) for 12 weeks. Blood pressure and proteinuria were examined and morphological studies on kidneys were performed. Results Remarkable proliferative changes in the afferent arteriolar SMCs were frequently observed in the group given ACEI; (66.1 ± 12.9%) compared with the control group (1.77 ± 1.56%, P<0.001). Conclusions It was indicated that long-term ACEI administration induced unusual proliferative changes in SMCs in afferent arterioles of ZFRs. These changes could reduce intraglomerular pressure by narrowing the lumens of afferent arterioles, but they could cause irreversible damage to the arterioles. |
format | Online Article Text |
id | pubmed-5364377 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Japan Society of Smooth Muscle Research |
record_format | MEDLINE/PubMed |
spelling | pubmed-53643772017-03-24 Changes in renal vessels associated with long-term administration of angiotensin converting enzyme inhibitor in Zucker fatty rats Nakanishi, Kazushige Nagai, Yohko Akimoto, Tatsuo Yamanaka, Nobuaki J Smooth Muscle Res Original Background Recently, we showed that long-term angiotensin receptor blocker (ARB) administration induced unusual proliferative changes in smooth muscle cells (SMCs) of afferent arterioles of the kidneys of Zucker fatty rats (ZFRs). In this study, we investigated renal afferent arteriolar changes induced by the long-term administration of an angiotensin converting enzyme inhibitor (ACEI) in ZFRs. Materials and Methods Fourteen 6-week-old male ZFRs were divided into two groups (n=14): the ZFR+ACEI group (n=6) was fed a standard diet containing ACEI (Enalapril, 2 mg/kg/day), and the ZFR control group (n=8) for 12 weeks. Blood pressure and proteinuria were examined and morphological studies on kidneys were performed. Results Remarkable proliferative changes in the afferent arteriolar SMCs were frequently observed in the group given ACEI; (66.1 ± 12.9%) compared with the control group (1.77 ± 1.56%, P<0.001). Conclusions It was indicated that long-term ACEI administration induced unusual proliferative changes in SMCs in afferent arterioles of ZFRs. These changes could reduce intraglomerular pressure by narrowing the lumens of afferent arterioles, but they could cause irreversible damage to the arterioles. Japan Society of Smooth Muscle Research 2017-03-03 2017 /pmc/articles/PMC5364377/ /pubmed/28260705 http://dx.doi.org/10.1540/jsmr.53.20 Text en ©2017 The Japan Society of Smooth Muscle Research This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. (CC-BY-NC-ND 4.0: http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Nakanishi, Kazushige Nagai, Yohko Akimoto, Tatsuo Yamanaka, Nobuaki Changes in renal vessels associated with long-term administration of angiotensin converting enzyme inhibitor in Zucker fatty rats |
title | Changes in renal vessels associated with long-term administration of
angiotensin converting enzyme inhibitor in Zucker fatty rats |
title_full | Changes in renal vessels associated with long-term administration of
angiotensin converting enzyme inhibitor in Zucker fatty rats |
title_fullStr | Changes in renal vessels associated with long-term administration of
angiotensin converting enzyme inhibitor in Zucker fatty rats |
title_full_unstemmed | Changes in renal vessels associated with long-term administration of
angiotensin converting enzyme inhibitor in Zucker fatty rats |
title_short | Changes in renal vessels associated with long-term administration of
angiotensin converting enzyme inhibitor in Zucker fatty rats |
title_sort | changes in renal vessels associated with long-term administration of
angiotensin converting enzyme inhibitor in zucker fatty rats |
topic | Original |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364377/ https://www.ncbi.nlm.nih.gov/pubmed/28260705 http://dx.doi.org/10.1540/jsmr.53.20 |
work_keys_str_mv | AT nakanishikazushige changesinrenalvesselsassociatedwithlongtermadministrationofangiotensinconvertingenzymeinhibitorinzuckerfattyrats AT nagaiyohko changesinrenalvesselsassociatedwithlongtermadministrationofangiotensinconvertingenzymeinhibitorinzuckerfattyrats AT akimototatsuo changesinrenalvesselsassociatedwithlongtermadministrationofangiotensinconvertingenzymeinhibitorinzuckerfattyrats AT yamanakanobuaki changesinrenalvesselsassociatedwithlongtermadministrationofangiotensinconvertingenzymeinhibitorinzuckerfattyrats |